Dopaminergic effects of lergotrile: possible involvement of a metabolite.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D004873:Ergolines / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects
D004873:Ergolines; D006892:Hydroxydopamines; D008781:Methyltyrosines; D011335:Proadifen; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine